Date
One of the global suppliers of heparin, China, has experienced active ingredient issues due to various reasons and this is expected to increase strain on other heparin suppliers.
As such, a proactive approach to conserving the stock we have in Northern Health is recommended.
NH has supply until end of October at the current usage rate; however, one of the primary vendors is on backorder until early October and if this is delayed further, there could be challenges with extending the current supply on hand.